about
Genome-wide association studies identify four ER negative-specific breast cancer risk lociPenetrance analysis of the PALB2 c.1592delT founder mutation.Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repairInactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in micePALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSLarge-scale genotyping identifies 41 new loci associated with breast cancer risk.Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European DescentNo clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer familiesMutation analysis of the AATF gene in breast cancer families.Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.Mutation screening of the MERIT40 gene encoding a novel BRCA1 and RAP80 interacting protein in breast cancer families2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.Mutation screening of the RNF8, UBC13 and MMS2 genes in Northern Finnish breast cancer families.Breast-cancer risk in families with mutations in PALB2Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families.Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancerParent-of-origin-specific allelic associations among 106 genomic loci for age at menarcheRare copy number variants observed in hereditary breast cancer cases disrupt genes in estrogen signaling and TP53 tumor suppression networkGenetic variation in mitotic regulatory pathway genes is associated with breast tumor gradeCommon non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association ConsortiumMicroRNA related polymorphisms and breast cancer risk.Recurrent CYP2C19 deletion allele is associated with triple-negative breast cancer.Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.Evaluation of the need for routine clinical testing of PALB2 c.1592delT mutation in BRCA negative Northern Finnish breast cancer familiesAssociations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general populationIdentification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer riskInherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.Assessment of targeted and non-targeted responses in cells deficient in ATM function following exposure to low and high dose X-rays.Genetic predisposition to in situ and invasive lobular carcinoma of the breast.Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association ConsortiumEvaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk.A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancerCommon germline polymorphisms associated with breast cancer-specific survival.
P50
Q24622610-4325F86B-3304-41D2-B380-61E3329D4B19Q27851443-599F358F-DD18-42F4-AE27-9D9EBAEBCF6BQ28267893-41BB87C7-039E-4DAA-982B-70B9A4AEF180Q28506416-04817161-0A82-44EE-9F9E-7B1C9D6BCDF0Q28584533-581FA9FD-6E26-4D17-8E5E-B30EA4C471F9Q29416989-74630245-5BA2-433A-A74B-262902EF7762Q30000080-9F133ECC-3AF6-4111-9B53-447295B8C66EQ30374367-697AE2AE-71A5-4616-B248-235CB9E26CA9Q31082788-270E61ED-44FB-4B5A-95E3-83479F395AEDQ33337514-3D19326F-8C62-44FD-9375-288CA7DF032FQ33520087-1045668A-E527-452B-A336-4EE84040B514Q33677756-339B50B0-096B-47D8-B0C7-202DB64C78D1Q33824592-83CA1035-106C-464D-A49A-EF336F7F5306Q33848895-BE56317E-F6B3-49D0-9F1A-98E3C7FBE23CQ33966572-ADF5AB03-5C97-45F2-9CEC-18318B2AC586Q34148873-5E8A1E42-520D-4790-A845-1500C5A1146CQ34173446-8A4DEA75-C585-4AE8-B2E3-AE5F5814988DQ34181322-703A04F8-46A5-4A17-A67A-7E5DB985EBE3Q34289136-8A45E592-1D60-4477-A7D1-62CCB54F01F5Q34318239-C80AD5E3-8EBF-45D4-B2CA-C2EC8EBC46E6Q34378972-EEF45BBC-8212-46D9-BCED-E73D3C8A7880Q34379032-64A2EE5E-DA86-468F-9DF7-C4C779A7E59CQ34497352-E56DD9C2-DB36-42EA-909A-314CC158C65FQ34695260-BC9D647F-D597-4FF1-B77E-98B2E7E6EAFCQ34903062-610A859B-2DA1-4D39-9110-B399FE79C60BQ34938728-E3374D7F-0BD6-42F4-AAE4-6D01F6D6B4FEQ35022847-40E06310-4A8F-4699-9C6D-47A89D75FF5CQ35064451-B213323A-6C96-41AF-A5CA-CA8FEAC3DFE2Q35089479-36495DC0-78D0-40B2-9063-ED341F981DEEQ35102646-DB9FCF93-CA59-4EC1-80F9-D5E09F2AD3C9Q35104068-F677D114-F9D0-469E-BA37-A1C033A4DAB0Q35134888-14233C38-9DA5-44E0-AE5E-874753FDCC67Q35151684-02B6D388-54F3-4355-A302-9E4381B1C30CQ35155449-F78674B5-3CBD-4A2F-823E-DEA8130216E5Q35179897-B765DF66-53BA-4361-8712-89381BFF6152Q35524465-F3EC9683-98E9-4E9F-83DB-58546621E57AQ35532898-2775A63A-85C4-4B60-86DD-C1CC0B0E9CDFQ35653910-C1B08343-B640-444D-9270-03690C8D8D8EQ35755874-21026270-625B-4DAA-89FD-9DDF04625E02Q35794653-9725AB59-1068-4C4D-992D-572C66EC0D6C
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Katri Pylkäs
@ast
Katri Pylkäs
@en
Katri Pylkäs
@es
Katri Pylkäs
@nl
Katri Pylkäs
@sl
type
label
Katri Pylkäs
@ast
Katri Pylkäs
@en
Katri Pylkäs
@es
Katri Pylkäs
@nl
Katri Pylkäs
@sl
altLabel
Pylkäs K
@en
prefLabel
Katri Pylkäs
@ast
Katri Pylkäs
@en
Katri Pylkäs
@es
Katri Pylkäs
@nl
Katri Pylkäs
@sl
P106
P1153
57202063768
P21
P31
P496
0000-0002-2449-0521